Stock screener
2All disclosures →
EDGAR →
OGN
Conviction 81HealthcareScan · Tue, Sep 8, 2026OGN$13.75-0.22%
ResistanceSupportVol 14Insider buyInsider sellCongress buyCongress sell2Vol MA14 3.86M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price13.75
Change-0.22%
Gap-0.07%
Rel volume2.09×
Avg volume3.55M
Avg $ vol48.81M
SMA 2013.74
SMA 5013.61
SMA 20010.31
Price vs 50+1.00%
Price vs 200+33.31%
MA stackbullish
50/200 cross—
Supertrendup · 13.68
RSI (14)65
MACD hist-0.01
MACD crossbear · 6d
Stoch %K / %D63 / 82
ADX (14)48
+DI / −DI19 / 14
RSI divergenceBearish
MACD divergenceBearish
ATR %+0.26%
ADR %0.25%
52w high13.78
52w low5.70
From 52w high-0.22%
Above 52w low+141.23%
New 52w highYes
SqueezeOff
Bollinger width1.06%
%B0.59
Donchian pos80.00%
Donchian high13.79
Donchian low13.61
AVWAP (52w high)13.76
vs AVWAP high-0.11%
AVWAP (52w low)12.15
vs AVWAP low+13.19%
OBV trendUp
Chaikin MF (20)0.10
Today vs 20d2.09×
Avg vol (14d)3.86M
Avg vol (20d)3.55M
Avg $ vol (20d)48.81M
Market cap3.61B
RS 3m (vs SPY)-1.28%
RS 6m (vs SPY)+95.51%
RS line new highNo
Trend template7/8
Technical rank82.2
1 week-0.07%
1 month+1.10%
3 months+2.69%
6 months+110.57%
1 year+32.47%
YTD+89.92%
P/E19.31
P/B3.59
P/S0.58
P/FCF6.71
EPS0.7200
Div yield2.44%
ROE18.59%
ROA1.42%
Debt/Eq8.45
Current1.95
EV/EBITDA—
Gross margin53.30%
Net margin3.01%
Rev growth-2.92%
EPS growth-78.36%
Price target—
Target upside—
Analyst rating—
Institutional98.50%
Ent. value10.98B
Revenue1.56B
Net income108M
Gross profit847M
Free cash flow538M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out262.6M
Employees10K
ListedFri, May 14, 2021
Free float261.47M
Float %99.6%
Short interest15.14M
Days to cover6.1d
Short volume69.0%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.80 vs $0.85
Last surprise-5.9% miss
Setup gradeA
Conviction81 / 100
Pattern quality—
Tech rank82.2 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance13.78
Support13.49
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in OGN · 3 recent
Insider activity
SEC Form 4 transactions in OGN · 4 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Arjona Ferreira Juan Camilo Head of R&D & CMO · Common Stock · 2026-08-11 | Exercise | 11.52K | — | 2026-08-11 | 2026-08-12 |
Arjona Ferreira Juan Camilo Head of R&D & CMO · Common Stock · 2026-08-11 | Tax | 4.13K | $56K | 2026-08-11 | 2026-08-12 |
Arjona Ferreira Juan Camilo Head of R&D & CMO · Restricted Stock Units · 2026-08-11 | Exercise | 11.52K | — | 2026-08-11 | 2026-08-12 |
Drinane Juliana Papa Head of Mfg & Supply · Common Stock · 2026-08-05 | Sell | 14.76K | $200K | 2026-08-05 | 2026-08-05 |
Holzbaur Lynette SVP and Corporate Controller · Common Stock · 2026-05-06 | Buy | 26.45K | $353K | 2026-05-06 | 2026-05-07 |
Holzbaur Lynette SVP and Corporate Controller · Common Stock · 2026-05-06 | Sell | 26.45K | $353K | 2026-05-06 | 2026-05-07 |
Holzbaur Lynette SVP and Corporate Controller · Common Stock · 2026-05-06 | Acquire | 45.939 | $0 | 2026-05-06 | 2026-05-07 |
SEC filings
EDGAR filings in OGN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.